What is NDC 0093-3655?

0093-3655 is the product NDC for Methylergonovine Maleate, Methylergonovine maleate .2 mg/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Methylergonovine Maleate?

13 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Methylergonovine Maleate NDC 0093-3655

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-3655Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-3655Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-3655-22	00093365522	12 TABLET in 1 BOTTLE (0093-3655-22)Marketed from Mar 26, 2019
0093-3655-28	00093365528	28 TABLET in 1 BOTTLE (0093-3655-28)Marketed from Mar 26, 2019

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methylergonovine Maleate
Generic name (nonproprietary): methylergonovine maleate
Active ingredients: Methylergonovine maleate — .2 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211455
Marketing start: Mar 26, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Ergolines (Chemical structure)
Identifiers: Product ID 0093-3655_cfe69331-16e9-4559-91d0-4d58a934d753SPL ID cfe69331-16e9-4559-91d0-4d58a934d753SPL set ID d8e4b8ed-3289-4611-8a61-2392a4bf6072RxCUI 996824UNII IR84JPZ1RK
Pharmacologic class: Ergot Derivative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093365522 followed by a unit qualifier and the quantity

Package 00093-3655-22. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Following delivery of the placenta, for routine management of uterine atony, hemorrhage and subinvolution of the uterus. For control of uterine hemorrhage in the second stage of labor following delivery of the anterior shoulder.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0093-3655

What is NDC 0093-3655?: 0093-3655 is the product NDC for Methylergonovine Maleate, Methylergonovine maleate .2 mg/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Methylergonovine Maleate.
What is the active ingredient?: Methylergonovine maleate.
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Methylergonovine Maleate?: 13 other product NDCs are listed under this name. See all Methylergonovine Maleate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Methylergonovine Maleate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Methylergonovine Maleate	Methylergonovine maleate .2 mg/1	TabletOral	Major Pharmaceuticals	0904-7282	00904-7282-10
Methylergonovine Maleate	Methylergonovine maleate .2 mg/1	TabletOral	American Health Packaging	60687-813	60687-0813-94
Methylergonovine Maleate	Methylergonovine maleate .2 mg/1	TabletOral	Volley Pharmaceuticals, LLC	83400-100	83400-0100-1283400-0100-28
Methylergonovine Maleate	Methylergonovine maleate .2 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1556	51662-1556-02
Methylergonovine Maleate	Methylergonovine maleate .2 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-735	16571-0735-0116571-0735-1716571-0735-21+1 more
Methylergonovine Maleatemethylergonovine	Methylergonovine maleate .2 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	69238-1605	69238-1605-0269238-1605-08
Methylergonovine Maleate	Methylergonovine maleate .2 mg/1	TabletOral	Granules Pharmaceuticals Inc.	70010-786	70010-0786-1270010-0786-28
Methylergonovine Maleate	Methylergonovine maleate .2 mg/mL	InjectionIntravenous	Breckenridge Pharmaceutical, Inc.	51991-144	51991-0144-17
Methylergonovine Maleate	Methylergonovine maleate .2 mg/mL	InjectionIntravenous	Bryant Ranch Prepack	63629-2074	63629-2074-01
Methylergonovine Maleate	Methylergonovine maleate .2 mg/mL	InjectionIntravenous	Bryant Ranch Prepack	72162-1592	72162-1592-02

All 14 Methylergonovine Maleate NDCs